***  For details on how to be removed from this list visit the  ***
***          CCP4 home page http://www.ccp4.ac.uk         ***


Thanks for taking the time to post this information!  We are at 9.3 right
now, and debating the 10.0 update.

Cheers,

Steve


-----Original Message-----
From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] On Behalf Of
Michael Strickler
Sent: Friday, November 18, 2005 12:11 PM
To: [email protected]
Subject: [ccp4bb]: "Success" Building CCP4 under SUSE 10.0


***  For details on how to be removed from this list visit the  ***
***          CCP4 home page http://www.ccp4.ac.uk         ***


After some false starts, we (mostly) successfully compiled CCP4 5.0.2 on
a system running SUSE Linux 10.0.  It required a few tweaks:

(1) Obviously, avoid the radical new gfortran compiler that is the
default for SUSE 10.0.  Install the compat-g77 package instead to use
g77 3.3.5.  Note that this prevents use of the SUSE BLAS/LAPACK
libraries, which require gfortran, so the LAPACK included with CCP4 has
to be used.

(2) setenv XCFLAGS "-DG77 -DPROTOTYPE"; otherwise the "-DHAVE_G2C_H"
flag gets added by configure, which causes the build to fail.

(3) The "--disable-pdb_extract" configure flag is necessary, as GCC is
still haunted by post-3.3.* issues.  Alas, no non-g77 compatibility
packages are currently available.

Apologies if this simply recapitulates someone else's findings for
Gentoo/Fedora/Darwin/Vista.

-- 
Michael Strickler, Ph.D.
Research Specialist
Center for Structural Biology
Yale University
260 Whitney Ave, 355C JWG
PO Box 208114
New Haven, CT 06520-8114



------------------------------------------------------------------------------
Notice:  This e-mail message, together with any attachments, contains 
information of Merck & Co., Inc. (One Merck Drive, Whitehouse Station, New 
Jersey, USA 08889), and/or its affiliates (which may be known outside the 
United States as Merck Frosst, Merck Sharp & Dohme or MSD and in Japan, as 
Banyu) that may be confidential, proprietary copyrighted and/or legally 
privileged. It is intended solely for the use of the individual or entity named 
on this message.  If you are not the intended recipient, and have received this 
message in error, please notify us immediately by reply e-mail and then delete 
it from your system.
------------------------------------------------------------------------------

Reply via email to